|
0
|
|
A MICA/B GAALIE-mutant antibody elicits potent natural killer cell-driven immunity in solid and hematologic malignancy models.
(linkinghub.elsevier.com)
|
Pimenta R
…
Ferrari de Andrade L
Cell Reports Medicine
2026-05-19
|
#antibody
#cancer
#immunotherapy
#engineering
#nk cell
|
|
0
|
|
Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapy.
(linkinghub.elsevier.com)
|
Bajgain P
…
St Croix B
Cell Reports Medicine
2026-05-19
|
#cancer
#immunotherapy
#car-t
#phage-display
#humanization
|
|
0
|
|
Antibody-drug conjugates in breast cancer: Progress and future directions.
(linkinghub.elsevier.com)
|
Bili Newman A
…
Meric-Bernstam F
Cell Reports Medicine
2026-05-19
|
#cancer
#immunotherapy
#biomarker
#drug delivery
|
|
0
|
|
Spleen-targeted neoantigen mRNA vaccine induces ISG15(+) CD8(+) T cell-mediated tertiary lymphoid structure formation in hepatocellular carcinoma.
(linkinghub.elsevier.com)
|
Lin X
…
Liu X
Cell Reports Medicine
2026-05-19
|
#vaccination
#immunity
#cancer
#immunotherapy
#neoantigen
|
|
0
|
|
Single-cell spatial analysis stratifies lung adenocarcinoma with rare actionable mutations and reveals immune-modulatory cellular crosstalk.
(linkinghub.elsevier.com)
|
Ma J
…
Zhang M
Cell Reports Medicine
2026-05-19
|
#immunotherapy
#single-cell
#spatial omics
#tumor microenvironment
#immune-checkpoint-inhibitors
|
|
0
|
|
Ferroptotic tumor cells reprogram tumor-associated macrophage antigen presentation to enhance the efficacy of immune checkpoint blockade.
(linkinghub.elsevier.com)
|
Sun JL
…
Zhu JM
Cell Reports Medicine
2026-05-19
|
#immunotherapy
#ferroptosis
#macrophage
#antigen-presentation
#tumor immunity
|
|
0
|
|
Taxane chemotherapy promotes response to TIM-3 checkpoint blockade via STING-mediated ER stress and HMGB1 secretion.
(linkinghub.elsevier.com)
|
Onimus A
…
Ruffell B
Cell Reports Medicine
2026-05-19
|
#inflammation
#immunotherapy
#chemotherapy
#sting
#dendritic cell
|
|
0
|
|
Dual-targeted microspheres reshape the metabolic-immune microenvironment to reverse post-embolization dilemmas in hepatocellular carcinoma.
(linkinghub.elsevier.com)
|
Jiang N
…
Cheng L
Cell Reports Medicine
2026-05-19
|
#metabolism
#immunity
#cancer
#immunotherapy
#angiogenesis
|
|
0
|
|
A tumor-intrinsic WNT-inhibitory NOTUM program drives immune resistance in microsatellite stable colorectal cancer.
(linkinghub.elsevier.com)
|
Chua J
…
Ayyaz A
Cell Reports Medicine
2026-05-19
|
#cancer
#immunotherapy
#colorectal cancer
#tumor microenvironment
#immune resistance
|
|
0
|
|
Debio 1562M CD37-targeting ADC is highly active and well tolerated in preclinical models of AML and MDS.
(linkinghub.elsevier.com)
|
Marx L
…
Ivanschitz L
Cell Reports Medicine
2026-05-19
|
#immunotherapy
#leukemia
#xenograft
#adc
#myelodysplasia
|
|
0
|
|
Reprogramming T cell-myeloid crosstalk overcomes immune resistance in colorectal cancer.
(linkinghub.elsevier.com)
|
Mestrallet G
…
Bhardwaj N
Cell Reports Medicine
2026-05-19
|
#immunity
#cancer
#immunotherapy
#checkpoint
#exhaustion
|
|
0
|
|
An inhalable microbe-oncolytic virus consortium for lung cancer treatment.
(linkinghub.elsevier.com)
|
Ling H
…
Sun M
Cell Reports Medicine
2026-05-19
|
#virulence
#cancer
#biofilm
#immunotherapy
#oncolytic
|
|
0
|
|
HPK1 inhibitor NDI-101150 as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: Phase 1/2 trial results.
(linkinghub.elsevier.com)
|
Braun DA
…
Sommerhalder D
Cell Reports Medicine
2026-05-19
|
#immunity
#cancer
#clinical trial
#immunotherapy
#biomarker
|
|
0
|
|
Targeting RNase H2: A dual-mechanism strategy to elevate replication stress, DNA damage, and antitumor immunity in TNBC.
(linkinghub.elsevier.com)
|
Nguyen TQA
…
Lin SY
Cell Reports Medicine
2026-05-19
|
#virulence
#immunity
#cancer
#immunotherapy
#dna damage
|
|
0
|
|
Nociceptive innervation limits tertiary lymphoid structures to promote lung cancer.
(linkinghub.elsevier.com)
|
Ho YH
…
Li L
Cell
2026-05-19
|
#immunity
#cancer
#inflammation
#immunotherapy
#neuroimmunology
|
|
0
|
|
T cell-engaging bispecific antibodies for myeloid malignancies: Targets, formats, and clinical challenges.
(linkinghub.elsevier.com)
|
Paczesny S
…
Cheung NV
Cell Reports Medicine
2026-05-19
|
#antibody
#immunotherapy
#toxicity
#leukemia
#hematologic
|